We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$7.91B
AUM Growth
-$1.76B
Cap. Flow
-$1.37B
Cap. Flow %
-17.29%
Top 10 Hldgs %
11.41%
Holding
2,902
New
788
Increased
705
Reduced
576
Closed
758

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$52.3M
2
EXC icon
Exelon
EXC
+$51.9M
3
LIN icon
Linde
LIN
+$48.3M
4
AMD icon
Advanced Micro Devices
AMD
+$41.5M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$39.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$251M
2
MSFT icon
Microsoft
MSFT
+$235M
3
AMZN icon
Amazon
AMZN
+$226M
4
CSGP icon
CoStar Group
CSGP
+$103M
5
AER icon
AerCap
AER
+$82.2M

Sector Composition

Rank Sector Weight
1 Technology 13.96%
2 Industrials 12.92%
3 Consumer Discretionary 9.79%
4 Financials 9.27%
5 Energy 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGS icon
2601
Regis Corp
RGS
$66.9M
-1,803
Closed -$63K
RLJ icon
2602
RLJ Lodging Trust
RLJ
$1.75B
-249,821
Closed -$3.48M
RMD icon
2603
ResMed
RMD
$33.4B
-20,273
Closed -$5.28M
ROCK icon
2604
Gibraltar Industries
ROCK
$1.38B
-3,439
Closed -$229K
ROL icon
2605
Rollins
ROL
$17.8B
-137,143
Closed -$4.69M
ROST icon
2606
Ross Stores
ROST
$76.7B
-42,389
Closed -$4.84M
RPID icon
2607
Rapid Micro Biosystems
RPID
$84.3M
-14,224
Closed -$151K
RPTX
2608
DELISTED
Repare Therapeutics
RPTX
-10,846
Closed -$229K
RVP icon
2609
Retractable Technologies
RVP
$21.9M
-12,655
Closed -$88K
RWAY icon
2610
Runway Growth Finance
RWAY
$278M
-10,134
Closed -$130K
RYZ
2611
Ryerson Holding Corp
RYZ
$1.31B
-8,813
Closed -$230K
RYTM icon
2612
Rhythm Pharmaceuticals
RYTM
$7.57B
-15,475
Closed -$154K
RZLT icon
2613
Rezolute
RZLT
$490M
-104,053
Closed -$497K
S icon
2614
SentinelOne
S
$7.26B
-219,839
Closed -$11.1M
SAM icon
2615
Boston Beer
SAM
$1.91B
-17,748
Closed -$8.96M
SANM icon
2616
Sanmina
SANM
$10.1B
-11,114
Closed -$461K
SBS icon
2617
Sabesp
SBS
$16.2B
-52,602
Closed -$75K
SBSI icon
2618
Southside Bancshares
SBSI
$956M
-5,089
Closed -$213K
SCCO icon
2619
Southern Copper
SCCO
$182B
-4,765
Closed -$269K
SCNI
2620
Scinai Immunotherapeutics
SCNI
$1.66M
-32
Closed -$74K
SCS
2621
DELISTED
Steelcase
SCS
-50,141
Closed -$588K
SHOE
2622
Shoe Station Group
SHOE
$420M
-14,436
Closed -$564K
SEDG icon
2623
SolarEdge
SEDG
$1.9B
-2,946
Closed -$827K
SEM
2624
DELISTED
Select Medical
SEM
-138,214
Closed -$2.19M
SENS icon
2625
Senseonics Holdings Inc
SENS
$513M
-3,091
Closed -$165K

Similar funds

Michael Gelband's Q1 2022 Portfolio in Review

As of Q1 2022, Michael Gelband held 2,902 positions worth $7.91B, down 18% from $9.67B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Michael Gelband withdrew a net $1.37B in Q1 2022, closing 758 positions and reducing 576 holdings. Its most notable exit was CoStar Group, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Michael Gelband opened a new position in Linde worth $49.9M.

  • Michael Gelband's largest Q1 2022 buy was Linde: 156,289 shares worth $49.9M.
  • Michael Gelband added most to ExxonMobil in Q1 2022, an estimated $52.3M increase.
  • Michael Gelband's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $251M.
  • Michael Gelband fully exited CoStar Group in Q1 2022, selling an estimated $103M.
  • Michael Gelband's ten largest holdings make up 11% of its $7.91B portfolio in Q1 2022.
  • Michael Gelband opened 788 new positions and closed 758 in Q1 2022.
  • Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.91B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.